相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Vascular Endothelial Growth Factor Receptor 2 as a Marker for Malignant Vascular Tumors and Mesothelioma: An Immunohistochemical Study of 262 Vascular Endothelial and 1640 Nonvascular Tumors
Markku Miettinen et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2012)
Expression and clinical significance of extracellular matrix protein 1 and vascular endothelial growth factor-C in lymphatic metastasis of human breast cancer
Qiu-Wan Wu et al.
BMC CANCER (2012)
MicroRNA-1826 targets VEGFC, beta-catenin (CTNNB1) and MEK1 (MAP2K1) in human bladder cancer
Hiroshi Hirata et al.
CARCINOGENESIS (2012)
Macrophages are important mediators of either tumor- or inflammation-induced lymphangiogenesis
Rui-Cheng Ji
CELLULAR AND MOLECULAR LIFE SCIENCES (2012)
The effects of vascular endothelial growth factor C knockdown in esophageal squamous cell carcinoma
Hongxin Zhang et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2012)
SIX1 induces lymphangiogenesis and metastasis via upregulation of VEGF-C in mouse models of breast cancer
Chu-An Wang et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Wnt1 Is Anti-Lymphangiogenic in a Melanoma Mouse Model
Heide Niederleithner et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2012)
Downregulation of VEGF-C expression in lung and colon cancer cells decelerates tumor growth and inhibits metastasis via multiple mechanisms
N. Khromova et al.
ONCOGENE (2012)
The Extra Domain A of Fibronectin Increases VEGF-C Expression in Colorectal Carcinoma Involving the PI3K/AKT Signaling Pathway
Lisha Xiang et al.
PLOS ONE (2012)
VEGF-C differentially regulates VEGF-A expression in ocular and cancer cells; promotes angiogenesis via RhoA mediated pathway
Bharat Kumar et al.
ANGIOGENESIS (2011)
Signal transduction by vascular endothelial growth factor receptors
Sina Koch et al.
BIOCHEMICAL JOURNAL (2011)
Reduced serum vascular endothelial growth factor receptor-2 (sVEGFR-2) and sVEGFR-1 levels in gastric cancer patients
Shogo Kikuchi et al.
CANCER SCIENCE (2011)
Rspo1/Wnt signaling promotes angiogenesis via Vegfc/Vegfr3
Aniket V. Gore et al.
DEVELOPMENT (2011)
RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways
Yukuan Feng et al.
EUROPEAN JOURNAL OF CANCER (2011)
Wnt1 is a proangiogenic molecule, enhances human endothelial progenitor function, and increases blood flow to ischemic limbs in a HGF-dependent manner
Costin M. Gherghe et al.
FASEB JOURNAL (2011)
Lymphatic Endothelial Heparan Sulfate Deficiency Results in Altered Growth Responses to Vascular Endothelial Growth Factor-C (VEGF-C)
Xin Yin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Lymphangiogenesis Linked to VEGF-C from Tumor-Associated Macrophages: Accomplices to Metastasis by Cutaneous Squamous Cell Carcinoma?
Martin S. Kluger et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2011)
Interleukin-6 signalling regulates vascular endothelial growth factor-C synthesis and lymphangiogenesis in human oral squamous cell carcinoma
Satoru Shinriki et al.
JOURNAL OF PATHOLOGY (2011)
VEGF binding to NRP1 is essential for VEGF stimulation of endothelial cell migration, complex formation between NRP1 and VEGFR2, and signaling via FAK Tyr407 phosphorylation
Birger Herzog et al.
MOLECULAR BIOLOGY OF THE CELL (2011)
VEGF and angiopoietin signaling in tumor angiogenesis and metastasis
Pipsa Saharinen et al.
TRENDS IN MOLECULAR MEDICINE (2011)
Sunitinib inhibits lymphatic endothelial cell functions and lymph node metastasis in a breast cancer model through inhibition of vascular endothelial growth factor receptor 3
Yasuo Kodera et al.
BREAST CANCER RESEARCH (2011)
Soluble VEGFR-2: an antilymphangiogenic variant of VEGF receptors
Helena Pavlakovic et al.
LYMPHATICS IN THE DIGESTIVE SYSTEM: PHYSIOLOGY, HEALTH, AND DISEASE (2010)
High VEGFC expression is associated with unique gene expression profiles and predicts adverse prognosis in pediatric and adult acute myeloid leukemia
Hendrik J. M. de Jonge et al.
BLOOD (2010)
Effective Suppression of Vascular Network Formation by Combination of Antibodies Blocking VEGFR Ligand Binding and Receptor Dimerization
Denis Tvorogov et al.
CANCER CELL (2010)
Suppression of Tumor Growth and Metastasis by Simultaneously Blocking Vascular Endothelial Growth Factor (VEGF)-A and VEGF-C with a Receptor-Immunoglobulin Fusion Protein
Dapeng Zhang et al.
CANCER RESEARCH (2010)
Role of interleukin-17 in lymphangiogenesis in non-small-cell lung cancer: Enhanced production of vascular endothelial growth factor C in non-small-cell lung carcinoma cells
Xi Chen et al.
CANCER SCIENCE (2010)
Lymphangiogenesis: Molecular Mechanisms and Future Promise
Tuomas Tammela et al.
CELL (2010)
Neuroblastoma Progression Correlates with Downregulation of the Lymphangiogenesis Inhibitor sVEGFR-2
Juergen Becker et al.
CLINICAL CANCER RESEARCH (2010)
The effect of the expression of vascular endothelial growth factor (VEGF)-C and VEGF receptor-3 on the clinical outcome in patients with gastric carcinoma
F. -H. Han et al.
EJSO (2010)
VEGF receptor 2/-3 heterodimers detected in situ by proximity ligation on angiogenic sprouts
Ingrid Nilsson et al.
EMBO JOURNAL (2010)
Transmembrane domain-mediated orientation of receptor monomers in active VEGFR-2 dimers
Debora Dell'Era Dosch et al.
FASEB JOURNAL (2010)
Mechanism of lymph node metastasis in prostate cancer
Kaustubh Datta et al.
FUTURE ONCOLOGY (2010)
Neuropilin-2 mediates VEGF-C-induced lymphatic sprouting together with VEGFR3
Yunling Xu et al.
JOURNAL OF CELL BIOLOGY (2010)
Vascular endothelial growth factor C (VEGF-C) in esophageal cancer correlates with lymph node metastasis and poor patient prognosis
Tatsuya Tanaka et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2010)
A critical role for lymphatic endothelial heparan sulfate in lymph node metastasis
Xin Yin et al.
MOLECULAR CANCER (2010)
Phage-Derived Fully Human Monoclonal Antibody Fragments to Human Vascular Endothelial Growth Factor-C Block Its Interaction with VEGF Receptor-2 and 3
Matthias Rinderknecht et al.
PLOS ONE (2010)
Structural determinants of growth factor binding and specificity by VEGF receptor 2
Veli-Matti Leppanen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Gonadotropin-Regulated Lymphangiogenesis in Ovarian Cancer Is Mediated by LEDGF-Induced Expression of VEGF-C
Stav Sapoznik et al.
CANCER RESEARCH (2009)
Vascular endothelial growth factor-C (VEGF-C) promotes angiogenesis by induction of COX-2 in leukemic cells via the VEGF-R3/JNK/AP-1 pathway
Ming-Hsien Chien et al.
CARCINOGENESIS (2009)
Vascular endothelial growth factor receptor-3 promotes breast cancer cell proliferation, motility and survival in vitro and tumor formation in vivo
Elena V. Kurenova et al.
CELL CYCLE (2009)
VEGFs and receptors involved in angiogenesis versus lymphangiogenesis
Marja Lohela et al.
CURRENT OPINION IN CELL BIOLOGY (2009)
VEGFR-2 silencing by small interference RNA (siRNA) suppresses LPA-induced epithelial ovarian cancer (EOC) invasion
Feng-qiang Wang et al.
GYNECOLOGIC ONCOLOGY (2009)
Snake Venom Vascular Endothelial Growth Factors (VEGF-Fs) Exclusively Vary Their Structures and Functions among Species
Yasuo Yamazaki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Lymphangiogenesis in gastric carcinoma correlates with prognosis
Peng Gao et al.
JOURNAL OF PATHOLOGY (2009)
Alternatively spliced vascular endothelial growth factor receptor-2 is an essential endogenous inhibitor of lymphatic vessel growth
Romulo J. C. Albuquerque et al.
NATURE MEDICINE (2009)
Serum vascular endothelial growth factor C correlates with lymph node metastases and high-risk tumor profiles in papillary thyroid carcinoma
Xiao-Min Yu et al.
ANNALS OF SURGERY (2008)
Neuropilin-1 in regulation of VEGF-induced activation of p38MAPK and endothelial cell organization
Harukiyo Kawamura et al.
BLOOD (2008)
Further evidence for expression and function of the VEGF-C/VEGFR-3 axis in cancer cells
Jen-Liang Su et al.
CANCER CELL (2008)
Blocking neuropilin-2 function inhibits tumor cell metastasis
Maresa Caunt et al.
CANCER CELL (2008)
Combination therapy with short interfering RNA vectors against VEGF-C and VEGF-A suppresses lymph node and lung metastasis in a mouse immunocompetent mammary cancer model
M-A Shibata et al.
CANCER GENE THERAPY (2008)
Vascular endothelial growth factor-mediated decrease in plasma soluble vascular endothelial growth, factor receptor-2 levels as a surrogate biomarker for tumor growth
John M. L. Ebos et al.
CANCER RESEARCH (2008)
The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis
Caroline A. Heckman et al.
CANCER RESEARCH (2008)
Suppression of prostate cancer nodal and systemic metastasis by blockade of the lymphangiogenic axis
Jeremy B. Burton et al.
CANCER RESEARCH (2008)
Vascular Endothelial Growth Factor C Stimulates Progression of Human Gastric Cancer via Both Autocrine and Paracrine Mechanisms
Michiyo Kodama et al.
CLINICAL CANCER RESEARCH (2008)
Endogenous vascular endothelial growth factor-C expression is associated with decreased drug responsiveness in childhood acute myeloid leukemia
Hendrik J. M. de Jonge et al.
CLINICAL CANCER RESEARCH (2008)
Multi-kinase inhibitor E7080 suppresses lymph node and lung metastases of human mammary breast tumor MDA-MB-231 via inhibition of vascular endothelial growth factor-receptor (VEGF-R) 2 and VEGF-R3 kinase
Junji Matsui et al.
CLINICAL CANCER RESEARCH (2008)
The clinical significance of lymphangiogenesis and angiogenesis in non-small cell lung cancer patients
Kyuichi Kadota et al.
EUROPEAN JOURNAL OF CANCER (2008)
Wnt1 overexpression promotes tumour progression in non-small cell lung cancer
Cheng-Long Huang et al.
EUROPEAN JOURNAL OF CANCER (2008)
Heparanase induces VEGF C and facilitates tumor lymphangiogenesis
Victoria Cohen-Kaplan et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation
Tuomas Tammela et al.
NATURE (2008)
VEGF-C expression in squamous cell carcinoma and adenocarcinoma of the esophagus
Christian Moebius et al.
WORLD JOURNAL OF SURGERY (2007)
Neuropilins in physiological and pathological angiogenesis
C. A. Staton et al.
JOURNAL OF PATHOLOGY (2007)
Vascular endothelial growth factor (VEGF) signaling in tumor progression
Robert Roskoski
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2007)
Genetic alteration of endothelial heparan sulfate selectively inhibits tumor angiogenesis
Mark M. Fuster et al.
JOURNAL OF CELL BIOLOGY (2007)
Prognostic significance of vascular endothelial cell growth factors -A, -C and -D in breast cancer and their relationship with angio- and lymphangiogenesis
R. A. A. Mohammed et al.
BRITISH JOURNAL OF CANCER (2007)
Cooperative and redundant roles of VEGFR-2 and VEGFR-3 signaling in adult lymphangiogenesis
Jeremy Goldman et al.
FASEB JOURNAL (2007)
VEGF-C-induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites
Satoshi Hirakawa et al.
BLOOD (2007)
Vascular endothelial growth factor receptor 3 is involved in tumor angiogenesis and growth
Pirjo Laakkonen et al.
CANCER RESEARCH (2007)
Imaging steps of lymphatic metastasis reveals that vascular endothelial growth factor-C increases metastasis by increasing delivery of cancer cells to lymph nodes: Therapeutic implications.
Tohru Hoshida et al.
CANCER RESEARCH (2006)
Neuropilin-2 interacts with VEGFR-2 and VEGFR-3 and promotes human endothelial cell survival and migration
Benoit Favier et al.
BLOOD (2006)
The balance of VEGF-C and VEGFR-3 mRNA is a predictor of lymph node metastasis in non-small cell lung cancer
H. Takizawa et al.
BRITISH JOURNAL OF CANCER (2006)
Functional interaction of VEGF-C and VEGF-D with neuropilin receptors
Terhi Karpanen et al.
FASEB JOURNAL (2006)
Biology of vascular endothelial growth factors
Himadri Roy et al.
FEBS LETTERS (2006)
Vascular endothelial growth factor (VEGF)/VEGF-C mosaic molecules reveal specificity determinants and feature novel receptor binding patterns
M Jeltsch et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
The VEGF-C/Flt-4 axis promotes invasion and metastasis of cancer cells
JL Su et al.
CANCER CELL (2006)
Inhibtion of VEGFR-3 activation with the antagonistic antibody more potently suppresses lymph node and distant metastases than inactivation of VEGFR-2
N Roberts et al.
CANCER RESEARCH (2006)
Prospects of RNA interference therapy for cancer
SI Pai et al.
GENE THERAPY (2006)
Nitric oxide in breast cancer: Induction of vascular endothelial growth factor-C and correlation with metastasis and poor prognosis
Y Nakamura et al.
CLINICAL CANCER RESEARCH (2006)
Lymphangiogenesis and angiogenesis in bladder cancer: Prognostic implications and regulation by vascular endothelial growth factors-A, -C, and -D
Y Miyata et al.
CLINICAL CANCER RESEARCH (2006)
Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis
Neta Ilan et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2006)
Peritumoral lymphatic vessel density and vascular endothelial growth factor C expression in early-stage squamous cell carcinoma of the uterine cervix
Z Gombos et al.
CLINICAL CANCER RESEARCH (2005)
Increased expression of vascular endothelial growth factor C in papillary thyroid carcinoma correlates with cervical lymph node metastases
XM Yu et al.
CLINICAL CANCER RESEARCH (2005)
Inhibition of lymphogenous metastasis using adeno-associated virus-mediated gene transfer of a soluble VEGFR-3 decoy receptor
JM Lin et al.
CANCER RESEARCH (2005)
Vascular endothelial growth factor-C expression and invasive phenotype in ovarian carcinomas
M Ueda et al.
CLINICAL CANCER RESEARCH (2005)
Expression of vascular endothelial growth factor receptor-3 (VEGFR-3) in human prostate
R Li et al.
PROSTATE (2004)
Vascular endothelial growth factor C and vascular endothelial growth factor receptor 2 are related closely to the prognosis of patients with ovarian carcinoma
N Nishida et al.
CANCER (2004)
Expression of vascular endothelial growth factor receptor-3 by lymphatic endothelial cells is associated with lymph node metastasis in prostate cancer
YP Zeng et al.
CLINICAL CANCER RESEARCH (2004)
Dual role of carcinoembryonic antigen-related cell adhesion molecule 1 in angiogenesis and invasion of human urinary bladder cancer
L Oliveira-Ferrer et al.
CANCER RESEARCH (2004)
Vegfc is required for vascular development and endoderm morphogenesis in zebrafish
EA Ober et al.
EMBO REPORTS (2004)
Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins
MJ Karkkainen et al.
NATURE IMMUNOLOGY (2004)
Ligand-induced vascular endothelial growth factor receptor-3 (VEGFR-3) heterodimerization with VEGFR-2 in primary lymphatic endothelial cells regulates tyrosine phosphorylation sites
J Dixelius et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Vascular endothelial growth factors C and D and lymphangiogenesis in gastrointestinal tract malignancy
SE Duff et al.
BRITISH JOURNAL OF CANCER (2003)
The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression
V Hanrahan et al.
JOURNAL OF PATHOLOGY (2003)
Up-regulation of vascular endothelial growth factor C in breast cancer cells by heregulin-β1
PW Tsai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Vascular endothelial growth factor-D is an independent prognostic factor in epithelial ovarian carcinoma
Y Yokoyama et al.
BRITISH JOURNAL OF CANCER (2003)
Vascular endothelial growth factor-C expression predicts lymph node metastasis of human gastric carcinomas invading the submucosa
T Amioka et al.
EUROPEAN JOURNAL OF CANCER (2002)
VEGF-C induced lymphangiogenesis is associated with lymph node metastasis in orthotopic MCF-7 tumors
MMT Mattila et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Correlation between vascular endothelial growth factor-C expression and invasion phenotype in cervical carcinomas
M Ueda et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Relative effects of VEGF-A and VEGF-C on endothelial cell proliferation, migration, and PAF synthesis: Role of neuropilin-1
PN Bernatchez et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2002)
Differential expression of neuropilin-1 and neuropilin-2 in arteries and veins
Y Herzog et al.
MECHANISMS OF DEVELOPMENT (2001)
Clinicopathological significance of vascular endothelial growth factor (VEGF)-C in human esophageal squamous cell carcinomas
Y Kitadai et al.
INTERNATIONAL JOURNAL OF CANCER (2001)
VEGF-A, VEGF-C, and VEGF-D in colorectal cancer progression
ML George et al.
NEOPLASIA (2001)
The expression of vascular endothelial growth factor C and its receptors in non-small cell lung cancer
T Kajita et al.
BRITISH JOURNAL OF CANCER (2001)
Novel VEGF family members: VEGF-B, VEGF-C and VEGF-D
XR Li et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2001)
Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis
SJ Mandriota et al.
EMBO JOURNAL (2001)
Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis
M Skobe et al.
NATURE MEDICINE (2001)
Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3
T Mäkinen et al.
NATURE MEDICINE (2001)
Clinical significance of vascular endothelial growth factor-C (VEGF-C) in breast cancer
J Kinoshita et al.
BREAST CANCER RESEARCH AND TREATMENT (2001)
Vascular endothelial growth factor-C (VEGF-C) expression in human colorectal cancer tissues
K Akagi et al.
BRITISH JOURNAL OF CANCER (2000)
分享论文
